Devanand Sarkar
Impact in
- Oncology top 0.2%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
- Pathology and Forensic Medicine top 0.1%
- Cancer Mechanisms and Therapy
Papers in
- Oncology 120
- CAR-T cell therapy research 39
- Peptidase Inhibition and Analysis 33
- Cytokine Signaling Pathways and Interactions 23
- Co-authors
- Paul B. Fisher (251 shared papers)Luni Emdad (88 shared papers)Swadesh K. Das (105 shared papers)Zao-zhong Su (34 shared papers)Luni Emdad (39 shared papers)Irina V. Lebedeva (40 shared papers)Seok‐Geun Lee (24 shared papers)Xiang‐Yang Wang (33 shared papers)
- Journals
- Cancer Research (36 papers)Advances in cancer research (26 papers)Proceedings of the National Academy of Sciences (22 papers)Journal of Cellular Physiology (22 papers)Oncogene (13 papers)
- Partner nations
- United StatesIndiaSouth Korea
In The Last Decade
Devanand Sarkar
300 papers receiving 17.9k citations
Devanand Sarkar's Hit Papers
Peers
Comparison fields: 5 of 150
- Oncology 5.6k
- Pathology and Forensic Medicine 3.7k
- Immunology 3.9k
- Cancer Research 2.0k
- Molecular Biology 8.1k
Countries citing papers authored by Devanand Sarkar
This map shows the geographic impact of Devanand Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devanand Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devanand Sarkar more than expected).
Fields of papers citing papers by Devanand Sarkar
This network shows the impact of papers produced by Devanand Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devanand Sarkar. The network helps show where Devanand Sarkar may publish in the future.
Co-authors
The 25 scholars most cited alongside Devanand Sarkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 303 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | I Hit paper breakdown → | 2004 | 948 |
| 2 | Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification Hit paper breakdown → | 2020 | 588 |
| 3 | Therapeutic Cancer Vaccines Hit paper breakdown → | 2013 | 464 |
| 4 | 2010 | 332 | |
| 5 | 2005 | 305 | |
| 6 | 2009 | 288 | |
| 7 | 2002 | 274 | |
| 8 | 2012 | 270 | |
| 9 | 2008 | 263 | |
| 10 | 2005 | 254 | |
| 11 | 2006 | 250 | |
| 12 | 2011 | 236 | |
| 13 | Emerging Therapies for Hepatocellular Carcinoma (HCC) Hit paper breakdown → | 2022 | 228 |
| 14 | 2012 | 222 | |
| 15 | 2008 | 209 | |
| 16 | 2014 | 206 | |
| 17 | 2006 | 198 | |
| 18 | 2007 | 193 | |
| 19 | 2013 | 185 | |
| 20 | 2003 | 174 |
About Devanand Sarkar
Devanand Sarkar is a scholar working on Molecular Biology, Oncology, Genetics, Pathology and Forensic Medicine and Immunology, having authored 303 papers that have together received 18.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (74 papers), Cancer Mechanisms and Therapy (74 papers), CAR-T cell therapy research (39 papers), Peptidase Inhibition and Analysis (33 papers), Hippo pathway signaling and YAP/TAZ (26 papers), Cancer Research and Treatments (25 papers), Cytokine Signaling Pathways and Interactions (23 papers) and Axon Guidance and Neuronal Signaling (19 papers). The work is most often cited by research in Oncology (5.6k citations), Pathology and Forensic Medicine (3.7k citations), Immunology (3.9k citations), Cancer Research (2.0k citations) and Molecular Biology (8.1k citations). Devanand Sarkar has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include Paul B. Fisher, Luni Emdad, Swadesh K. Das, Zao-zhong Su, Luni Emdad, Irina V. Lebedeva, Seok‐Geun Lee, Xiang‐Yang Wang, Saranya Chidambaranathan Reghupaty and Paul Dent. Their work appears in journals such as Cancer Research, Advances in cancer research, Proceedings of the National Academy of Sciences, Journal of Cellular Physiology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.